Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Cefuroxime sodium 750 mg, 1.5 g Injection, powder Marsam Pharmaceuticals Inc., Cherry Hill, New Jersey, United States of America Cefuroxime Haemophilus type b conjugate vaccine (N.meningitidis group B OMP conjugate) 7.5 g, hepatitis b vaccine (rDNA) 5 g per 0.5 mL dose Injection, suspension Merck & Co Inc., West Point, Pennsylvania, United States of America Comvax Light liquid paraffin 6% w/w, white soft paraffin 15% w/w Cream, topical Stiefel Laboratories (Ireland) Limited, Sligo, Eire Oilatum Piroxicam 10 mg, 20 mg Tablet, dispersible Salutas Pharma GmbH., Barleben, Germany Pirohexal-D Amoxycillin trihydrate 294.9 mg equivalent to 250 mg amoxycillin, potassium clavulanate 148.8 mg equivalent to 125 mg clavulanic acid; amoxycillin trihydrate 589.8 mg equivalent to 500 mg amoxycillin, potassium clavulanate 148.8 mg equivalent to 125 mg clavulanic acid Tablets, film coated Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India Synermox Verapamil hydrochloride 40 mg, 80 mg, 120 mg Tablets, film coated Salutas Pharma GmbH., Barleben, Germany Verahexal Verapamil hydrochloride 240 mg Tablet, modified release Salutas Pharma GmbH., Barleben, Germany Verahexal SR Dated this 19th day of May 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.